TP53 and cancer: Research has shown that mutations in the TP53 gene are the most frequent of all genetic alterations in HNC and are associated with cancer invasiveness, distant metastasis formation, and cancer proliferation, which leads to higher cancer aggressiveness, thus lowering the survival rate of patients despite treatment [23,24].